Clinical Trial Update: Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated dabigatran's effect on changes in atrial fibrosis in patients with atrial fibrillation; the study was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: University of Utah | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2015-10-12